United States Biotechnology & Medical Research

Kaleido Biosciences Inc (KLDO)

Track

Ticker: KLDO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Menichella Daniel L
Chief Executive Officer
1 purchase — total 230,000 USD
Buy 8 Feb 2021
Value US$1,592,658.16 | Price 334.49 | Shares 99,485
Buy 8 Feb 2021
Value US$3,333,956.63 | Price 397.67 | Shares 7,727
Buy 8 Feb 2021
Value US$1,189,233.97 | Price 20.01 | Shares 21,268
Buy 8 Feb 2021
Value US$824,159.00 | Price 11.50 | Shares 71,666
Buy 4 Jun 2020
Value US$4,999,995.00 | Price 7.50 | Shares 666,666
Buy 4 Jun 2020
Value US$5,000,002.50 | Price 7.50 | Shares 666,667
Buy 4 Jun 2020
Value US$5,000,002.50 | Price 7.50 | Shares 666,667
Buy 4 Jun 2020
Value US$249,997.50 | Price 7.50 | Shares 33,333
Buy 4 Mar 2019
Value US$4,999,995.00 | Price 15.00 | Shares 333,333
Buy 4 Mar 2019
Value US$4,999,995.00 | Price 15.00 | Shares 333,333
Buy 4 Mar 2019
Value US$4,000,005.00 | Price 15.00 | Shares 266,667
Buy 28 Feb 2019
Value US$37,430.75 | Price 14.65 | Shares 2,555
Buy 28 Feb 2019
Value US$962,061.75 | Price 13.95 | Shares 68,965
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-02-26 2021-02-08 B Purchase
Menichella Daniel L

Chief Executive Officer

Executive Director
99,485 +3.3%
334.49
US$1,592,658 		99,485 +3.3% 334.49 US$1,592,658
2021-02-10 2021-02-08 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
7,727 +46.2%
397.67
US$3,333,957 		7,727 +46.2% 397.67 US$3,333,957
2021-02-10 2021-02-08 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
21,268 -28.6%
20.01
US$1,189,234 		21,268 -28.6% 20.01 US$1,189,234
2021-02-10 2021-02-08 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
71,666 +4.4%
11.50
US$824,159 		71,666 +4.4% 11.50 US$824,159
2020-06-08 2020-06-04 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
666,666 +inf%
7.50
US$4,999,995 		666,666 +inf% 7.50 US$4,999,995
2020-06-08 2020-06-04 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
666,667 +29.7%
7.50
US$5,000,002 		666,667 +29.7% 7.50 US$5,000,002
2020-06-08 2020-06-04 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
666,667 +70.4%
7.50
US$5,000,002 		666,667 +70.4% 7.50 US$5,000,002
2020-06-05 2020-06-04 B Purchase
2.4
MELAS KYRIAZI THEO
Non-Executive Director
33,333 +inf%
7.50
US$249,998 		33,333 +inf% 7.50 US$249,998
2019-03-06 2019-03-04 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
333,333 +17.4%
15.00
US$4,999,995 		333,333 +17.4% 15.00 US$4,999,995
2019-03-06 2019-03-04 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
333,333 +5.4%
15.00
US$4,999,995 		333,333 +5.4% 15.00 US$4,999,995
2019-03-06 2019-03-04 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
266,667 +11.6%
15.00
US$4,000,005 		266,667 +11.6% 15.00 US$4,000,005
2019-03-04 2019-02-28 B Purchase
3.0
BONNEY MICHAEL W

Executive Chair

Executive Director
2,555 +0.3%
14.65
US$37,431 		2,555 +0.3% 14.65 US$37,431
2019-03-04 2019-02-28 B Purchase
3.0
BONNEY MICHAEL W

Executive Chair

Executive Director
68,965 +7.4%
13.95
US$962,062 		68,965 +7.4% 13.95 US$962,062
Explore more

More insider trading research around Kaleido Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America